Malignant rhabdoid tumor of the liver: Case report and literature review

Pathology International

Volumn 54, Issue 8, 2004, Pages 623-629

  Yuri, Takashi ^a   Danbara, Naoyuki ^a   Shikata, Nobuaki ^a   Fujimoto, Sachiko ^a   Nakano, Takahide ^a   Sakaida, Noriko ^a   Uemura, Yoshiko ^a   Tsubura, Airo ^a  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

Author keywords

Cytokeratin; Immunohistochemistry; Liver; Malignant rhabdoid tumor; Ultrastructure; Vimentin

Indexed keywords

ALPHA FETOPROTEIN; CISPLATIN; CYCLOPHOSPHAMIDE; CYTOKERATIN; CYTOKERATIN 1; CYTOKERATIN 10; CYTOKERATIN 13; CYTOKERATIN 14; CYTOKERATIN 15; CYTOKERATIN 16; CYTOKERATIN 17; CYTOKERATIN 18; CYTOKERATIN 19; CYTOKERATIN 20; CYTOKERATIN 7; CYTOKERATIN 8; DACTINOMYCIN; DESMIN; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; FLUOROURACIL; IFOSFAMIDE; MYOGLOBIN; TAMOXIFEN; UNCLASSIFIED DRUG; VIMENTIN; VINCRISTINE;

ABDOMINAL BLEEDING; ABDOMINAL SWELLING; ANAMNESIS; ARTIFICIAL EMBOLISM; AUTOPSY; CANCER CELL; CANCER CHEMOTHERAPY; CASE REPORT; CAUSE OF DEATH; CELL INCLUSION; CLINICAL FEATURE; CYTOPLASM; DISSEMINATED INTRAVASCULAR CLOTTING; DYSPNEA; EOSINOPHIL; FEMALE; FEVER; HEPATIC ARTERY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFANT; LABORATORY TEST; LIVER CANCER; LIVER HEMORRHAGE; LIVER RESECTION; LIVER WEIGHT; MALIGNANT NEOPLASTIC DISEASE; NUCLEOLUS; PANCYTOPENIA; PRIORITY JOURNAL; REVIEW; RHABDOID TUMOR; ULTRASTRUCTURE;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; FATAL OUTCOME; FEMALE; HEMORRHAGE; HUMANS; IMMUNOHISTOCHEMISTRY; INCLUSION BODIES; INFANT; LIVER NEOPLASMS; RHABDOID TUMOR; TUMOR MARKERS, BIOLOGICAL;

EID: 4344666667     PISSN: 13205463     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1827.2004.01672.x     Document Type: Review

References (28)

1. Beckwith JB, Palmer NF. Histopathology and prognosis of Wilms tumor: results from the First National Wilms' Tumor Study. Cancer 1978; 41: 1937-48.
2. Gonzalez-Crussie F, Goldschmidt RA, Hsueh W, Trujillo Y. Infantile sarcoma with intracytoplasmic inclusions. A distinctive tumor of possible histiocytic origin. Cancer 1982; 49: 2365-75.
3. Weeks DA, Beckwith JB, Mierau GW, Luckey DW. Rhabdoid tumor of kidney: a report of 111 cases from the National Wilms' Tumor Study Pathology Center. Am J Surg Pathol 1989; 13: 439-58.
4. Haas JE, Palmer NF, Weinberg AG, Beckwith JB. Ultrastructure of malignant rhabdoid tumor of the kidney. A distinct renal tumor of children. Hum Pathol 1981; 12: 646-57.
5. Scheimberg I, Cullinane C, Kelsey A, Malone M. Primary hepatic malignant tumor with rhabdoid features. A histological immunocytochemical, and electron microscopic study of four cases and a review of the literature. Am J Surg Pathol 1996; 204: 1394-400.
6. Moll R, Franke WW, Schiller DL, Geiger B, Krepler R. The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells. Cell 1982; 31: 11-24.
7. Moll R, Lowe A, Laufer J, Franke WW. Cytokeratin 20 in human carcinomas. A new histodiagnostic marker detected by monoclonal antibodies. Am J Pathol 1992; 40: 427-47.
8. Foschini MP, Van Eyken P, Brock PR et al. Malignant rhabdoid tumor of the liver. A case report. Histopathology 1992; 20: 157-65.
9. Kaiserling E, Ruck P, Handgretinger R, Leipoldt M, Hipfel R. Immunohistochemical and cytogenetic findings in malignant rhabdoid tumor. General Diagn Pathol 1996; 141: 327-37.
10. Shiratsuchi H, Oshiro Y, Saito T et al. Cytokeratin subunits of inclusion bodies in rhabdoid cells: Immunohistochemical study of malignant rhabdoid tumor and epithelioid sarcoma. Int J Surg Pathol 2001; 9: 37-48.
11. Kelly DM, Jones M, Humphreys S, Howard ER. Spontaneous rupture of a malignant rhabdoid tumor of the liver. Pediatr Surg Int 1998; 14: 111-12.
12. Ravindra KV, Cullinane C, Lewis IJ, Squire BR, Stringer MD. Long-term survival after spontaneous rupture of a malignant rhabdoid tumor of the liver. J Pediatr Surg 2002; 37: 1488-90.
13. Sotelo-Avila C, Gonzalez-Crussi F, deMello D et al. Renal and extrarenal rhabdoid tumors in children. a clinicopathological study of 14 patients. Semin Diagn Pathol 1986; 3: 151-63.
14. Shiratsuchi H, Saito T, Sakamoto A et al. Mutation analysis of human cytokeratin 8 gene in malignant rhabdoid tumor: a possible association with intracytoplasmic inclusion body formation. Mod Pathol 2002; 15: 146-53.
15. Ogino S, Ro JY, Redline RW. Malignant rhabdoid tumor: a phenotype? An entity? A controversy revisited. Adv Anat Pathol 2000; 7: 181-90.
16. Parham DM, Peiper SC, Robicheaux G, Ribeiro RC, Douglass EC. Malignant rhabdoid tumor of the liver. Evidence for epithelial differentiation. Arch Pathol Lab Med 1988; 112: 61-4.
17. Hunt SJ, Anderson WD. Malignant rhabdoid tumor of the liver. A distinct clinicopathologic entity. Am J Clin Pathol 1990; 84: 645-8.
18. Di Cori S, Oudjhane K, Neilson K. Primary malignant rhabdoid tumor of the liver. Can Assoc Radiol J 1993; 44: 52-4.
19. Weyman C, Dolson L, Kedar A. Secretion of vasointestinal peptide by a primary liver tumor with rhabdoid features. J Surg Oncol 1993; 54: 267-70.
20. Jimenez-Heffnernan JA, Lopez-Ferrer P, Burgos E, Viguer JM. Pathological case of the month. Primary hepatic malignant tumor with rhabdoid features. Arch Pediatr Adolesc Med 1998; 152: 509-10.
21. White FV, Dehner LP, Belchis DA et al. Congenital disseminated malignant rhabdoid tumor. A distinct clinicopathologic entity demonstrating abnormalities of chromosome 22q11. Am J Surg Pathol 1999; 23: 249-56.
22. Donner LR, Rao A, Truss LM, Dobin SM. Translocation (8;13)(q24.2;q33) in a malignant rhabdoid tumor of the liver. Cancer Genet Cytogenet 2000; 15: 153-7.
23. Katzenstein HM, Kletzel M, Reynolds M, Superina R, Gonzalez-Crussi F. Metastatic malignant rhabdoid tumor of the liver treated with tandem high-dose therapy and autologous peripheral blood stem cell rescue. Med Pediatr Oncol 2003; 40: 199-201.
24. Koshida S, Narita T, Kato H et al. Estrogen receptor expression and estrogen-receptor-independent cytotoxic effects of tamoxifen on malignant rhabdoid tumor cells in vitro. Jpn J Cancer Res 2002; 93: 1351-7.
25. Schofield DE, Beckwith JB, Sklar J. Loss of heterozygosity at chromosome regions 22q11-12 and 11p15.5 in renal rhabdoid tumors. Genes Chromosomes Cancer 1996; 15: 10-17.
26. Versteege I, Sevenet N, Lange J et al. Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer. Nature 1998; 394: 203-6.
27. Biegel JA, Allen CS, Kawasaki K, Shimizu N, Budarf ML, Bell CJ. Narrowing the critical region for a rhabdoid tumor locus in 22q11. Genes Chpromosomes Cancer 1996; 16: 94-105.
28. Simons J, Teshima I, Zielenska M et al. Analysis of chromosome 22q as an aid to the diagnosis of rhabdoid tumor: a case report. Am J Surg Pathol 1999; 23: 982-8.